PATENT CLAIM ANALYSIS

Application Number: 15975999
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "235200"]

Abstract:
A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, and circulatory system diseases

Claim (Index 4):
The method of  claim 1 , wherein the mammal is human.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.46154
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15373091', '14906993', '15539530', '15034905', '10477254']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7979609203293379
- 35 USC 102 Novelty (BERT): 0.5567458700047028
- Combined Prediction Score: 0.7738394152968743
- Mean Citation Score: 403.94175600000005
- Max Citation Score: 538.35376
- Similarity Product: 249.66146250191693

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test